UK to get 60m trial vaccines

Advanced Search

The story appears on

Page A11

July 30, 2020

GET this page in PDF

Free for subscribers

View shopping cart

UK to get 60m trial vaccines

Source: AFP | 00:05 UTC+8 July 30, 2020 |

Print Edition

Pharma giants Sanofi and GSK said yesterday they have agreed to supply Britain with up to 60 million doses of a potential COVID-19 vaccine.

The agreement covers a vaccine candidate developed by France’s Sanofi in partnership with the UK’s GSK and is subject to a “final contract.”

Amid the global race to find a vaccine to halt the pandemic, Sanofi announced “ongoing discussions with the European Commission, with France and Italy on the negotiation team, and other governments to ensure global access to a novel coronavirus vaccine.”

Both companies voiced in a statement their commitment “to making their COVID-19 vaccine candidate affordable and available globally.”

The vaccine candidate “has the potential to play a significant role in overcoming the COVID-19 pandemic, both in the UK and around the world,” said GSK Vaccines President Roger Connor.

World

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403号-1
|
互联网新闻信息服务许可证：31120180004
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

UK to get 60m trial vaccines

Email this to your friend